• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

National Institutes of Health (NIH)

U of Maryland scientist to set up NIH’s new Advanced Research Projects Agency for Health

May 26, 2022 By Sean Whooley

U.S. Dept. of Health and Human Services (HHS) announced that it formed a new research project agency for health. HHS Secretary Xavier Becerra announced the formal establishment of the Advanced Research Project Agency for Health (ARPA-H) as an independent entity within the National Institutes of Health (NIH). Adam H. Russell was appointed as acting deputy […]

Filed Under: Pharmaceutical Tagged With: Dept. of Health & Human Services (HHS), National Institutes of Health (NIH), Personnel Moves

NIH to study allergic reactions to COVID-19 mRNA vaccine

March 9, 2022 By Sean Whooley

Researchers from the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical trial on allergic reactions to mRNA-based COVID-19 vaccines. The single-site trial will enroll up to 100 people between 16 and 69 years old who had an allergic reaction to a first dose of COVID-19 mRNA vaccines. NIAID seeks participants […]

Filed Under: Clinical Trials, Featured, Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Pfizer

NIH launches $9.8M neuromodulation competition

January 18, 2022 By Sean Whooley

The National Institutes of Health (NIH) announced today that it launched the first phase of its Neuromod Prize competition. Neuromod Prize, a $9.8 million competition, aims to accelerate the development of neuromodulation therapies. NIH seeks scientists, engineers and clinicians to submit novel concepts and clinical development plans to demonstrate solutions for stimulating the peripheral nervous […]

Filed Under: Bioelectronic Medicine, Business/Financial News, Featured, Funding Roundup, Neurological, Neuromodulation/Neurostimulation, Pain Management, Research & Development Tagged With: National Institutes of Health (NIH), NIH

NIH director Francis Collins to step down

October 5, 2021 By Sean Whooley

The National Institutes of Health (NIH) announced today that Dr. Francis S. Collins will step down as director of the agency. Collins, the longest-serving presidentially-appointed NIH director, decided to end his tenure by the end of the year. He had served three U.S. presidents over more than 12 years. NIH did not announce a successor […]

Filed Under: Business/Financial News, Featured, Research & Development Tagged With: National Institutes of Health (NIH), NIH, Personnel Moves

NIAID expresses concern over AstraZeneca’s COVID-19 vaccine data

March 23, 2021 By Sean Whooley

The National Institute of Allergy and Infectious Diseases (NIAID) has announced concerns with data from AstraZeneca’s COVID-19 vaccine trial. NIAID, a wing of the National Institutes of Health (NIH), said in a statement today that it was concerned that information the company released from its AZD1222 vaccine clinical trial may be outdated. In turn, that […]

Filed Under: Clinical Trials, Featured, Pharmaceutical, Regulatory/Compliance Tagged With: AstraZeneca, coronavirus, COVID-19, COVID-19 vaccine, COVID-19 vaccine trial, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)

Quidel wins FDA nod for at-home antigen test

March 1, 2021 By Nancy Crotti

The FDA issued an emergency use authorization today for the Quidel Corp. (NSDW:QDEL) QuickVue At-Home COVID-19 test, another antigen test to rapidly collect and test samples at home, without the need to send a sample to a laboratory for analysis. The QuickVue At-Home COVID-19 test is authorized for prescription home use with self-collected nasal swab […]

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Abbott, antigen test, CareEvolution, coronavirus, COVID-19, Ellume, National Institutes of Health (NIH), Quidel Corp.

NIH increases PhysIQ contract to $6.6M

January 19, 2021 By Sean Whooley

PhysIQ announced today that the National Institutes of Health (NIH) entered into Phase II of a contract for its AI-based COVID-19 biomarker. A Purdue University-affiliated artificial intelligence company, PhysIQ’s AI-based COVID-19 digital biomarker is being developed to address the rapid decompensation of high-risk COVID-19 patients, according to a news release. PhysIQ’s technology’s cloud platform continuously […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Funding Roundup, Health Technology, Patient Monitoring, Software / IT Tagged With: coronavirus, COVID-19, national cancer institute, National Institutes of Health (NIH), physiq

Spark Biomedical wins FDA breakthrough nod for newborn opioid withdrawal relief device

December 16, 2020 By Nancy Crotti

Spark Biomedical announced today that the FDA granted breakthrough device designation to its transcutaneous electrical nerve stimulator designed to reduce signs and symptoms of neonatal opioid withdrawal syndrome (NOWS). NOWS results from exposure to prescription or non-prescription opioids such as methadone or heroin during pregnancy. Currently, no nationwide standard of care exists for managing NOWS, although […]

Filed Under: Bioelectronic Medicine, Featured, Food & Drug Administration (FDA), Hospital Care, Neuromodulation/Neurostimulation, Pediatrics, Regulatory/Compliance Tagged With: FDA, National Institutes of Health (NIH), opioid crisis, Spark Biomedical

Study: ECMO ‘significantly’ improves heart attack patients’ survival

November 13, 2020 By Sean Whooley

The National Institutes of Health (NIH) is touting a study that found the use of life support improved survival in certain cardiac arrest patients. Published in The Lancet, the study, known as the Advanced Reperfusion Strategies for Refractory Cardiac Arrest (ARREST) trial, used the life support machine called extracorporeal membrane oxygenation ECMO to replicate the […]

Filed Under: Cardiovascular, Clinical Trials, Featured Tagged With: Abiomed, and Blood Institute NHLBI, coronavirus, COVID-19, LivaNova, Medtronic, National Institutes of Health (NIH)

NIAID halts Lilly COVID-19 antibody study

October 27, 2020 By Nancy Crotti

An arm of NIH has ended a clinical trial investigating the use of Eli Lilly’s (NYSE:LLY) monoclonal antibody LY-CoV555 (bamlanivimab) to treat hospitalized COVID-19 patients. While the drug shows promise in treating mild-to-moderate COVID-19 infections, the ACTIV-3 trial involving severe cases of the disease showed little benefit, according to the National Institute of Allergy and Infectious Diseases […]

Filed Under: Business/Financial News, Clinical Trials Tagged With: coronavirus, COVID-19, Eli Lilly & Co., National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)

Minnetronix lands NIH grant to study spinal fluid treatment tech

October 20, 2020 By Nancy Crotti

Minnetronix Medical today announced that it has been awarded a National Institutes of Health (NIH) grant for continued study of its proprietary Neurapheresis cerebrospinal fluid treatment platform. Akin to hemodialysis, the Neurapheresis platform is designed to rapidly remove blood cells and their cytotoxic byproducts that are released into cerebrospinal fluid following an aneurysmal subarachnoid hemorrhage. Get […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Funding Roundup, Neurological, Research & Development Tagged With: Minnetronix Medical, National Institutes of Health (NIH)

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 11
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS